Member Info for jdt1990

You do t want an answer to that because it never happened. Waste of time poster

Hear hear Timster. So many crying for this RNS over the last couple of weeks and now they’re not happy because it’s a bit vague. What did they expect? We were told the next RNS milestones but bedwetters just couldn’t wait. Can’t make this up!

Bashers out in force today. SP drop is also a result of Oxford vaccine effectiveness numbers being released, easy for the MMs to drop the price on a combo of this and a slightly vague RNS.
Balisbak - if you think everything here depends on the bl**dy LFT think again and I’ll say it til I am blue in the face. Do some research! If the below happens on time - that is a HUGE Q4!
“ Furthermore, we remain on track to submit the UK regulatory application, or CTA, for AVA6000 pro-doxorubicin before the end of the year to allow first-in-human trials of the pre|CISIONTM chemotherapy platform at several clinical trial sites in the UK early in 2021.”

PL75 - I think AS had just run out of space in his inbox of worried PIs crying about lack of updates so in a bid to free up some space succumbed to the pier pressure and put out the “everything is okay” RNS.
Given the vaccine news, the fact they are pushing ahead with everything gives me confidence we’ll still make plenty of revenue from this. Delayed yes - but if a jobs worth doing it’s worth doing properly.

There needs to be news when the next milestone in any of the areas we are waiting on is reached. Simple as!
Not an RNS next week to tell nervous PIs to keep calm all is in hand.
AS has said we will sell every test we can produce - if he didn’t believe that post vaccine news we would have heard about an abandon ship scenario. Which hasn’t happened.
And even if the LFT never happened....there is so much more to this company including what could be a revolutionary therapeutics division!

Agreed Very odd posting history Potter. I feel serial deramper. Not just a holder peed of with the current situation like myself.
Know the risks and choose to stay here as I believe the project is economically very viable.
Placing at 1p chat is ridiculous. If there is one it would be at minimal discount. Let’s hope not and this all gets sown up 30 Nov!

The takeover idea is interesting tombi. It would be a great scenario if the board and LC held a significant number of shares and someone was willing to basically pay them to p*ss off and run this properly. I would be all for that. Sadly, LC holds 0.5% of the shares in issue so no skin in the game and it’s just too easy for him to take a monster salary for as long as he needs. I’d love someone to buy us out but think that wouldn’t suit LC and the little set up he has going on.

Be careful sensetalka - I couldn’t agree more with you but PC Potter and constable joyous will have you for trying to steal their shares airing that caution on the bb!

Agreed Mode could be a real dark horse investment here.

That should say without symptoms not with....surely nobody is that stupid? Or are they?
Some of the comments on this thread provide some entertaining but quite scary insights - some saturday reading

https://mobile.twitter.com/NadineDorries/status/1323541425187966978

Oh dear another COViD conspiracy crazy....yeah they want a shed load of false positives to lock everyone up, cripple the economy and create a great reset. Wow.
Was probably one of those posting “what’s the point in testing people with symptoms” and “get your legals ready it’s against our human rights to be force tested - the army are coming”
Beggars belief really

Kong - I think the issue here is two fold.
1. All the big dogs have been working on vaccines. These are multi billion £ corporations who have almost infinite resource. They can jump straight in at the deep end and p*ss as much money up the wall on the vaccine.
Avct and many others in the testing space have had to go it alone with no support. Avct had to raise £45m through the fund raise to support the business whilst this went on. Trying to produce the lft will no doubt cost money but if it was a failure that could be catastrophic for the business as a whole. Sunk costs arent easily just swallowed up. AS has to tread very carefully with what he ploughs resource into. Imagine if the govt had provided some kind of grant/funding. Eat out to help out cost £552m.
2. To Vegas’ point, quite criminally it seems, the vaccine progress has been mainly political and corporate d*ck swinging and looks to have bypassed a lot of red tape. No CONDOR delays there!
If the testing piece it was easy, the big boys would have done it but they’ve clearly chosen another route with the vaccine. Just a shame the ingenuity behind something we really need hasn’t been supported with any physical backing

Can't really argue with any of that destitute. I just pray the additional parties here POW and Graham Briggs keep him on the straight and narrow. He has nobody to stop him running riot over at KIBO.
Just over a week and all will be revealed....

I would disagree with Norfolk and destitute there. A deal will most likely be done, the asset is too attractive for financiers to walk away from really. Its more a case of when and if the when is significantly further down the track, what are the possible impacts in terms of cash burn / dilution that could hurt the potential upside.
The only way potential partners will walk away is if LC plays hard ball for a deal they aren't all willing to accept. (Very unlikely if you believe there was always 14 interested parties). LC is on the back foot in these discussions so I would imagine one of those partners will get get a good deal - how good and how much impact to shareholders again remains to be seen.
Luckily at £7m mkt cap even a shambolic deal has to be worth more than that. He cant screw this up....can he?

Avacta were 20p per share pre Covid Wolves but don't forget the Covid related spike allowed AVCT to raise £45m, the bulk of which is being used to push the therapeutics business forward at pace, projects that would have otherwise been shelved for a long time.
Whilst you can't deny AVCT is currently pretty much fully correlated to Covid related developments, I tihnk oxygens point was that it really shouldn't be. I 100% agree with that, AVCT has a hell of a lot more going for it outside of the LFT and some pretty solid partnerships with major pharmas in other areas that were in place before Covid was even a thing.
That's the issue here - many are blinkered by the desperate need for the LFT but that's not what this business set out to do and AS would jeapordise the reputation or financial stability of the business to hurry that through at the expense of other also pivotal business areas.
Conifer, Daewoong, Moderna etc will all have done their due diligence. This Co. is far more than a Covid play and £50m on the balance sheet values the business very differently pre and post covid outbreak..

LC doesnt run POW

But apparently AS isn't doing anything Nixynoo and just galivanting around buying houses, feet up on the desk drinking Yorkshire tea ignoring PI's "are we there yet" emails and scoffing fish and chips.
Just shows how many investors here jumped in on the COvid bandwagon, overexposed themselves and now cant hold to ride out the full story.
I would imagine there are a fair few draft email in AS's inbox that just read "IF ONLY YOU KNEW HOW MUCH WE WERE WORKING ON!"

It could be - funny how all the focus on LFT/BAMS has left this RNS from end of July to go well under the radar. Daewoong must have liked what they saw with their initial deal and liked it even more to expand that.

From 29Jul RNS
Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents is pleased to announce an expansion of its collaboration and license agreement with Daewoong Pharmaceutical Co. Ltd. (KSX: 069620) and AffyXell Therapeutics, the joint venture established in South Korea by the two companies, to develop stem cell treatments incorporating Avacta's neutralising Affimer therapy for the treatment of seriously ill patients with COVID-19 and to also prepare to rapidly develop similar therapies for future global pandemics.

Respiratory diseases such as ?COVID-19 can cause serious damage to the lungs as a consequence of over-activation of the patient's immune system, resulting in cytokine release syndrome that can potentially lead to multiple organ failure and death. Stem cell therapies offer a very promising approach to repair the damage to lung tissues in these pulmonary diseases by controlling the immune balance.

AffyXell Therapeutics, the next-generation cell and gene therapy joint venture between Avacta and Daewoong Pharmaceutical, is developing a novel class of mesenchymal stem cell (MSC) treatments that are engineered to also produce Affimer therapies in the patient at the site of action.

The expansion of the agreement between Avacta, Daewoong Pharmaceutical and AffyXell announced today extends the scope of the partnership to include Affimer molecules that target viruses, such as coronaviruses, in order to develop therapies that repair the lung damage caused by COVID-19 whilst also producing neutralising Affimer molecules to prevent the progression of the disease.

AffyXell will engineer mesenchymal stem cells to express SARS-COV-2 neutralising Affimer molecules in order to develop treatments for seriously ill COVID-19 patients, and will also prepare for rapid development of next-generation stem cell therapies for future infectious respiratory disease outbreaks.

bump

Completely fair Joyus and we're all in here to make some money. I don't for a second think this wont get over the line at some point....its too attractive not to for any potential suitor.
I guess my point simply is if there is 1.3m oz in those tailings, at current POG $1850 and an AISC of $950 that equates to:
1.3m * 900 /1.3 = £900m
So of course £7 mkt cap is absurdly undervalued....
However, selfishly I want as much of that asset value to be reflected in the value of my shareholding as possible. Having a fairly inept man at the helm in LC who has no skin in the game (therefore no risk as he still gets a monster salary) means that any poor deals or delays which could (I hope not) lead to dilution to pay said salary, hits me/us not him.
Hope that explains my stance a bit better?